We previously reported that arginine catabolism in the breast was shifted from the immune-stimulatory NO synthesis pathway toward the immune-suppressive PA synthesis pathway during breast tumor progression, especially for HER2-positive tumors. Here, ERBB2 is linked to breast neoplasm.